世界の抗核抗体（ANA）検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antinuclear Antibody (ANA) Test Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0404 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、抗核抗体（ANA）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（試薬・アッセイキット、システム、ソフトウェア・サービス）、用途別市場規模（病院、臨床検査室、診療所検査室、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・抗核抗体（ANA）検査の市場動向 ・企業の競争状況、市場シェア ・抗核抗体（ANA）検査の種類別市場規模（試薬・アッセイキット、システム、ソフトウェア・サービス） ・抗核抗体（ANA）検査の用途別市場規模（病院、臨床検査室、診療所検査室、その他） ・抗核抗体（ANA）検査の北米市場規模2016-2027（アメリカ、カナダ） ・抗核抗体（ANA）検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗核抗体（ANA）検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗核抗体（ANA）検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗核抗体（ANA）検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Bio-Rad Laboratories, Inc、ERBA Diagnostics, Inc、Trinity Biotech plc、Thermo Fisher Scientific, Inc、Antibodies, Inc、EUROIMMUN AG、Immuno Concepts、Inova Diagnostics、Zeus Scientific） ・結論

An ANA (antinuclear antibody) test looks for antinuclear antibodies in your blood. If the test finds antinuclear antibodies in your blood, it may mean you have an autoimmune disorder. An autoimmune disorder causes your immune system to attack your own cells, tissues, and/or organs by mistake. These disorders can cause serious health problems.
Antibodies are proteins that your immune system makes to fight foreign substances like viruses and bacteria. But an antinuclear antibody attacks your own healthy cells instead. It’s called “antinuclear” because it targets the nucleus (center) of the cells.

Market Analysis and Insights: Global Antinuclear Antibody (ANA) Test Market
The global Antinuclear Antibody (ANA) Test market size is projected to reach US$ 1476.1 million by 2026, from US$ 909.1 million in 2019, at a CAGR of 7.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antinuclear Antibody (ANA) Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antinuclear Antibody (ANA) Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antinuclear Antibody (ANA) Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antinuclear Antibody (ANA) Test market.

Global Antinuclear Antibody (ANA) Test Scope and Market Size
Antinuclear Antibody (ANA) Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antinuclear Antibody (ANA) Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Reagents & Assay Kits
Systems
Software & Service

Segment by Application
Hospitals
Clinical Laboratories
Physician Office Laboratories
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Bio-Rad Laboratories, Inc
ERBA Diagnostics, Inc
Trinity Biotech plc
Thermo Fisher Scientific, Inc
Antibodies, Inc
EUROIMMUN AG
Immuno Concepts
Inova Diagnostics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antinuclear Antibody (ANA) Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Reagents & Assay Kits
1.2.3 Systems
1.2.4 Software & Service
1.3 Market by Application
1.3.1 Global Antinuclear Antibody (ANA) Test Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Physician Office Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antinuclear Antibody (ANA) Test Market Perspective (2016-2027)
2.2 Antinuclear Antibody (ANA) Test Growth Trends by Regions
2.2.1 Antinuclear Antibody (ANA) Test Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antinuclear Antibody (ANA) Test Historic Market Share by Regions (2016-2021)
2.2.3 Antinuclear Antibody (ANA) Test Forecasted Market Size by Regions (2022-2027)
2.3 Antinuclear Antibody (ANA) Test Industry Dynamic
2.3.1 Antinuclear Antibody (ANA) Test Market Trends
2.3.2 Antinuclear Antibody (ANA) Test Market Drivers
2.3.3 Antinuclear Antibody (ANA) Test Market Challenges
2.3.4 Antinuclear Antibody (ANA) Test Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antinuclear Antibody (ANA) Test Players by Revenue
3.1.1 Global Top Antinuclear Antibody (ANA) Test Players by Revenue (2016-2021)
3.1.2 Global Antinuclear Antibody (ANA) Test Revenue Market Share by Players (2016-2021)
3.2 Global Antinuclear Antibody (ANA) Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antinuclear Antibody (ANA) Test Revenue
3.4 Global Antinuclear Antibody (ANA) Test Market Concentration Ratio
3.4.1 Global Antinuclear Antibody (ANA) Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antinuclear Antibody (ANA) Test Revenue in 2020
3.5 Antinuclear Antibody (ANA) Test Key Players Head office and Area Served
3.6 Key Players Antinuclear Antibody (ANA) Test Product Solution and Service
3.7 Date of Enter into Antinuclear Antibody (ANA) Test Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antinuclear Antibody (ANA) Test Breakdown Data by Type
4.1 Global Antinuclear Antibody (ANA) Test Historic Market Size by Type (2016-2021)
4.2 Global Antinuclear Antibody (ANA) Test Forecasted Market Size by Type (2022-2027)

5 Antinuclear Antibody (ANA) Test Breakdown Data by Application
5.1 Global Antinuclear Antibody (ANA) Test Historic Market Size by Application (2016-2021)
5.2 Global Antinuclear Antibody (ANA) Test Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antinuclear Antibody (ANA) Test Market Size (2016-2027)
6.2 North America Antinuclear Antibody (ANA) Test Market Size by Type
6.2.1 North America Antinuclear Antibody (ANA) Test Market Size by Type (2016-2021)
6.2.2 North America Antinuclear Antibody (ANA) Test Market Size by Type (2022-2027)
6.2.3 North America Antinuclear Antibody (ANA) Test Market Size by Type (2016-2027)
6.3 North America Antinuclear Antibody (ANA) Test Market Size by Application
6.3.1 North America Antinuclear Antibody (ANA) Test Market Size by Application (2016-2021)
6.3.2 North America Antinuclear Antibody (ANA) Test Market Size by Application (2022-2027)
6.3.3 North America Antinuclear Antibody (ANA) Test Market Size by Application (2016-2027)
6.4 North America Antinuclear Antibody (ANA) Test Market Size by Country
6.4.1 North America Antinuclear Antibody (ANA) Test Market Size by Country (2016-2021)
6.4.2 North America Antinuclear Antibody (ANA) Test Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Antinuclear Antibody (ANA) Test Market Size (2016-2027)
7.2 Europe Antinuclear Antibody (ANA) Test Market Size by Type
7.2.1 Europe Antinuclear Antibody (ANA) Test Market Size by Type (2016-2021)
7.2.2 Europe Antinuclear Antibody (ANA) Test Market Size by Type (2022-2027)
7.2.3 Europe Antinuclear Antibody (ANA) Test Market Size by Type (2016-2027)
7.3 Europe Antinuclear Antibody (ANA) Test Market Size by Application
7.3.1 Europe Antinuclear Antibody (ANA) Test Market Size by Application (2016-2021)
7.3.2 Europe Antinuclear Antibody (ANA) Test Market Size by Application (2022-2027)
7.3.3 Europe Antinuclear Antibody (ANA) Test Market Size by Application (2016-2027)
7.4 Europe Antinuclear Antibody (ANA) Test Market Size by Country
7.4.1 Europe Antinuclear Antibody (ANA) Test Market Size by Country (2016-2021)
7.4.2 Europe Antinuclear Antibody (ANA) Test Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size (2016-2027)
8.2 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Type
8.2.1 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Type (2016-2027)
8.3 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Application
8.3.1 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Application (2016-2027)
8.4 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Region
8.4.1 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antinuclear Antibody (ANA) Test Market Size (2016-2027)
9.2 Latin America Antinuclear Antibody (ANA) Test Market Size by Type
9.2.1 Latin America Antinuclear Antibody (ANA) Test Market Size by Type (2016-2021)
9.2.2 Latin America Antinuclear Antibody (ANA) Test Market Size by Type (2022-2027)
9.2.3 Latin America Antinuclear Antibody (ANA) Test Market Size by Type (2016-2027)
9.3 Latin America Antinuclear Antibody (ANA) Test Market Size by Application
9.3.1 Latin America Antinuclear Antibody (ANA) Test Market Size by Application (2016-2021)
9.3.2 Latin America Antinuclear Antibody (ANA) Test Market Size by Application (2022-2027)
9.3.3 Latin America Antinuclear Antibody (ANA) Test Market Size by Application (2016-2027)
9.4 Latin America Antinuclear Antibody (ANA) Test Market Size by Country
9.4.1 Latin America Antinuclear Antibody (ANA) Test Market Size by Country (2016-2021)
9.4.2 Latin America Antinuclear Antibody (ANA) Test Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size (2016-2027)
10.2 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Type
10.2.1 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Type (2016-2027)
10.3 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Application
10.3.1 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Application (2016-2027)
10.4 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Country
10.4.1 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Antinuclear Antibody (ANA) Test Introduction
11.1.4 Abbott Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Bio-Rad Laboratories, Inc
11.2.1 Bio-Rad Laboratories, Inc Company Details
11.2.2 Bio-Rad Laboratories, Inc Business Overview
11.2.3 Bio-Rad Laboratories, Inc Antinuclear Antibody (ANA) Test Introduction
11.2.4 Bio-Rad Laboratories, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021)
11.2.5 Bio-Rad Laboratories, Inc Recent Development
11.3 ERBA Diagnostics, Inc
11.3.1 ERBA Diagnostics, Inc Company Details
11.3.2 ERBA Diagnostics, Inc Business Overview
11.3.3 ERBA Diagnostics, Inc Antinuclear Antibody (ANA) Test Introduction
11.3.4 ERBA Diagnostics, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021)
11.3.5 ERBA Diagnostics, Inc Recent Development
11.4 Trinity Biotech plc
11.4.1 Trinity Biotech plc Company Details
11.4.2 Trinity Biotech plc Business Overview
11.4.3 Trinity Biotech plc Antinuclear Antibody (ANA) Test Introduction
11.4.4 Trinity Biotech plc Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021)
11.4.5 Trinity Biotech plc Recent Development
11.5 Thermo Fisher Scientific, Inc
11.5.1 Thermo Fisher Scientific, Inc Company Details
11.5.2 Thermo Fisher Scientific, Inc Business Overview
11.5.3 Thermo Fisher Scientific, Inc Antinuclear Antibody (ANA) Test Introduction
11.5.4 Thermo Fisher Scientific, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021)
11.5.5 Thermo Fisher Scientific, Inc Recent Development
11.6 Antibodies, Inc
11.6.1 Antibodies, Inc Company Details
11.6.2 Antibodies, Inc Business Overview
11.6.3 Antibodies, Inc Antinuclear Antibody (ANA) Test Introduction
11.6.4 Antibodies, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021)
11.6.5 Antibodies, Inc Recent Development
11.7 EUROIMMUN AG
11.7.1 EUROIMMUN AG Company Details
11.7.2 EUROIMMUN AG Business Overview
11.7.3 EUROIMMUN AG Antinuclear Antibody (ANA) Test Introduction
11.7.4 EUROIMMUN AG Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021)
11.7.5 EUROIMMUN AG Recent Development
11.8 Immuno Concepts
11.8.1 Immuno Concepts Company Details
11.8.2 Immuno Concepts Business Overview
11.8.3 Immuno Concepts Antinuclear Antibody (ANA) Test Introduction
11.8.4 Immuno Concepts Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021)
11.8.5 Immuno Concepts Recent Development
11.9 Inova Diagnostics
11.9.1 Inova Diagnostics Company Details
11.9.2 Inova Diagnostics Business Overview
11.9.3 Inova Diagnostics Antinuclear Antibody (ANA) Test Introduction
11.9.4 Inova Diagnostics Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021)
11.9.5 Inova Diagnostics Recent Development
11.10 Zeus Scientific
11.10.1 Zeus Scientific Company Details
11.10.2 Zeus Scientific Business Overview
11.10.3 Zeus Scientific Antinuclear Antibody (ANA) Test Introduction
11.10.4 Zeus Scientific Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021)
11.10.5 Zeus Scientific Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antinuclear Antibody (ANA) Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Reagents & Assay Kits
Table 3. Key Players of Systems
Table 4. Key Players of Software & Service
Table 5. Global Antinuclear Antibody (ANA) Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Antinuclear Antibody (ANA) Test Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Antinuclear Antibody (ANA) Test Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Antinuclear Antibody (ANA) Test Market Share by Regions (2016-2021)
Table 9. Global Antinuclear Antibody (ANA) Test Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Antinuclear Antibody (ANA) Test Market Share by Regions (2022-2027)
Table 11. Antinuclear Antibody (ANA) Test Market Trends
Table 12. Antinuclear Antibody (ANA) Test Market Drivers
Table 13. Antinuclear Antibody (ANA) Test Market Challenges
Table 14. Antinuclear Antibody (ANA) Test Market Restraints
Table 15. Global Antinuclear Antibody (ANA) Test Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Antinuclear Antibody (ANA) Test Market Share by Players (2016-2021)
Table 17. Global Top Antinuclear Antibody (ANA) Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antinuclear Antibody (ANA) Test as of 2020)
Table 18. Ranking of Global Top Antinuclear Antibody (ANA) Test Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Antinuclear Antibody (ANA) Test Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antinuclear Antibody (ANA) Test Product Solution and Service
Table 22. Date of Enter into Antinuclear Antibody (ANA) Test Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antinuclear Antibody (ANA) Test Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Antinuclear Antibody (ANA) Test Revenue Market Share by Type (2016-2021)
Table 26. Global Antinuclear Antibody (ANA) Test Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Antinuclear Antibody (ANA) Test Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Antinuclear Antibody (ANA) Test Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Antinuclear Antibody (ANA) Test Revenue Market Share by Application (2016-2021)
Table 30. Global Antinuclear Antibody (ANA) Test Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Antinuclear Antibody (ANA) Test Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Antinuclear Antibody (ANA) Test Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Antinuclear Antibody (ANA) Test Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Antinuclear Antibody (ANA) Test Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Antinuclear Antibody (ANA) Test Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Antinuclear Antibody (ANA) Test Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Antinuclear Antibody (ANA) Test Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Antinuclear Antibody (ANA) Test Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Antinuclear Antibody (ANA) Test Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Antinuclear Antibody (ANA) Test Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Antinuclear Antibody (ANA) Test Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Antinuclear Antibody (ANA) Test Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Antinuclear Antibody (ANA) Test Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Antinuclear Antibody (ANA) Test Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Antinuclear Antibody (ANA) Test Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Antinuclear Antibody (ANA) Test Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Antinuclear Antibody (ANA) Test Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Antinuclear Antibody (ANA) Test Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Antinuclear Antibody (ANA) Test Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Antinuclear Antibody (ANA) Test Product
Table 65. Abbott Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Bio-Rad Laboratories, Inc Company Details
Table 68. Bio-Rad Laboratories, Inc Business Overview
Table 69. Bio-Rad Laboratories, Inc Antinuclear Antibody (ANA) Test Product
Table 70. Bio-Rad Laboratories, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021) & (US$ Million)
Table 71. Bio-Rad Laboratories, Inc Recent Development
Table 72. ERBA Diagnostics, Inc Company Details
Table 73. ERBA Diagnostics, Inc Business Overview
Table 74. ERBA Diagnostics, Inc Antinuclear Antibody (ANA) Test Product
Table 75. ERBA Diagnostics, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021) & (US$ Million)
Table 76. ERBA Diagnostics, Inc Recent Development
Table 77. Trinity Biotech plc Company Details
Table 78. Trinity Biotech plc Business Overview
Table 79. Trinity Biotech plc Antinuclear Antibody (ANA) Test Product
Table 80. Trinity Biotech plc Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021) & (US$ Million)
Table 81. Trinity Biotech plc Recent Development
Table 82. Thermo Fisher Scientific, Inc Company Details
Table 83. Thermo Fisher Scientific, Inc Business Overview
Table 84. Thermo Fisher Scientific, Inc Antinuclear Antibody (ANA) Test Product
Table 85. Thermo Fisher Scientific, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021) & (US$ Million)
Table 86. Thermo Fisher Scientific, Inc Recent Development
Table 87. Antibodies, Inc Company Details
Table 88. Antibodies, Inc Business Overview
Table 89. Antibodies, Inc Antinuclear Antibody (ANA) Test Product
Table 90. Antibodies, Inc Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021) & (US$ Million)
Table 91. Antibodies, Inc Recent Development
Table 92. EUROIMMUN AG Company Details
Table 93. EUROIMMUN AG Business Overview
Table 94. EUROIMMUN AG Antinuclear Antibody (ANA) Test Product
Table 95. EUROIMMUN AG Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021) & (US$ Million)
Table 96. EUROIMMUN AG Recent Development
Table 97. Immuno Concepts Company Details
Table 98. Immuno Concepts Business Overview
Table 99. Immuno Concepts Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021) & (US$ Million)
Table 100. Immuno Concepts Recent Development
Table 101. Inova Diagnostics Company Details
Table 102. Inova Diagnostics Business Overview
Table 103. Inova Diagnostics Antinuclear Antibody (ANA) Test Product
Table 104. Inova Diagnostics Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021) & (US$ Million)
Table 105. Inova Diagnostics Recent Development
Table 106. Zeus Scientific Company Details
Table 107. Zeus Scientific Business Overview
Table 108. Zeus Scientific Antinuclear Antibody (ANA) Test Product
Table 109. Zeus Scientific Revenue in Antinuclear Antibody (ANA) Test Business (2016-2021) & (US$ Million)
Table 110. Zeus Scientific Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antinuclear Antibody (ANA) Test Market Share by Type: 2020 VS 2027
Figure 2. Reagents & Assay Kits Features
Figure 3. Systems Features
Figure 4. Software & Service Features
Figure 5. Global Antinuclear Antibody (ANA) Test Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinical Laboratories Case Studies
Figure 8. Physician Office Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Antinuclear Antibody (ANA) Test Report Years Considered
Figure 11. Global Antinuclear Antibody (ANA) Test Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Antinuclear Antibody (ANA) Test Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Antinuclear Antibody (ANA) Test Market Share by Regions: 2020 VS 2027
Figure 14. Global Antinuclear Antibody (ANA) Test Market Share by Regions (2022-2027)
Figure 15. Global Antinuclear Antibody (ANA) Test Market Share by Players in 2020
Figure 16. Global Top Antinuclear Antibody (ANA) Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antinuclear Antibody (ANA) Test as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Antinuclear Antibody (ANA) Test Revenue in 2020
Figure 18. Global Antinuclear Antibody (ANA) Test Revenue Market Share by Type (2016-2021)
Figure 19. Global Antinuclear Antibody (ANA) Test Revenue Market Share by Type (2022-2027)
Figure 20. North America Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Antinuclear Antibody (ANA) Test Market Share by Type (2016-2027)
Figure 22. North America Antinuclear Antibody (ANA) Test Market Share by Application (2016-2027)
Figure 23. North America Antinuclear Antibody (ANA) Test Market Share by Country (2016-2027)
Figure 24. United States Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Antinuclear Antibody (ANA) Test Market Share by Type (2016-2027)
Figure 28. Europe Antinuclear Antibody (ANA) Test Market Share by Application (2016-2027)
Figure 29. Europe Antinuclear Antibody (ANA) Test Market Share by Country (2016-2027)
Figure 30. Germany Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Antinuclear Antibody (ANA) Test Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Antinuclear Antibody (ANA) Test Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Antinuclear Antibody (ANA) Test Market Share by Region (2016-2027)
Figure 40. China Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Antinuclear Antibody (ANA) Test Market Share by Type (2016-2027)
Figure 48. Latin America Antinuclear Antibody (ANA) Test Market Share by Application (2016-2027)
Figure 49. Latin America Antinuclear Antibody (ANA) Test Market Share by Country (2016-2027)
Figure 50. Mexico Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Antinuclear Antibody (ANA) Test Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Antinuclear Antibody (ANA) Test Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Antinuclear Antibody (ANA) Test Market Share by Country (2016-2027)
Figure 56. Turkey Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Antinuclear Antibody (ANA) Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2016-2021)
Figure 60. Bio-Rad Laboratories, Inc Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2016-2021)
Figure 61. ERBA Diagnostics, Inc Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2016-2021)
Figure 62. Trinity Biotech plc Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2016-2021)
Figure 63. Thermo Fisher Scientific, Inc Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2016-2021)
Figure 64. Antibodies, Inc Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2016-2021)
Figure 65. EUROIMMUN AG Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2016-2021)
Figure 66. Immuno Concepts Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2016-2021)
Figure 67. Inova Diagnostics Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2016-2021)
Figure 68. Zeus Scientific Revenue Growth Rate in Antinuclear Antibody (ANA) Test Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---